1. Home
  2. BCIC vs OM Comparison

BCIC vs OM Comparison

Compare BCIC & OM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BCIC

BCP Investment Corporation

N/A

Current Price

$7.45

Market Cap

93.0M

Sector

Finance

ML Signal

N/A

Logo Outset Medical Inc.

OM

Outset Medical Inc.

N/A

Current Price

$4.57

Market Cap

87.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BCIC
OM
Founded
2006
2003
Country
United States
United States
Employees
13
N/A
Industry
Finance: Consumer Services
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
93.0M
87.7M
IPO Year
N/A
2020

Fundamental Metrics

Financial Performance
Metric
BCIC
OM
Price
$7.45
$4.57
Analyst Decision
Hold
Strong Buy
Analyst Count
2
3
Target Price
$9.00
$13.33
AVG Volume (30 Days)
60.4K
164.7K
Earning Date
05-07-2026
05-07-2026
Dividend Yield
14.14%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$119,476,000.00
Revenue This Year
$0.00
$9.29
Revenue Next Year
N/A
$10.99
P/E Ratio
$7.27
N/A
Revenue Growth
N/A
5.09
52 Week Low
$7.11
$3.00
52 Week High
$13.50
$21.36

Technical Indicators

Market Signals
Indicator
BCIC
OM
Relative Strength Index (RSI) 44.17 50.14
Support Level $7.19 $4.06
Resistance Level $8.26 $4.88
Average True Range (ATR) 0.20 0.42
MACD 0.02 -0.04
Stochastic Oscillator 39.29 21.19

Price Performance

Historical Comparison
BCIC
OM

About BCIC BCP Investment Corporation

BCP Investment Corp is an externally managed, non-diversified closed-end investment company. The company invests in secured term loans, bonds or notes and mezzanine debt in privately-held middle market companies. Its investment objective is to generate current income and, to a lesser extent, capital appreciation from the investments in senior secured term loans, mezzanine debt and selected equity investments in privately-held middle market companies.

About OM Outset Medical Inc.

Outset Medical Inc is a medical technology company pioneering a technology to reduce the cost and complexity of dialysis. The Company generates revenue from the sales of Tablo consoles and related consumables, including Tablo cartridges and accessories.

Share on Social Networks: